CDR-Life
Basel, Switzerland · $76.0M raised
- Headquarters
- Basel
- Business Model
- B2B
- Website
- cdr-life.com
- Total Funding
- $76.0M
- Last Round
- $76.0M Series AApr 2022
- Rounds
- 1
About
CDR-Life develops highly selective T-cell engagers targeting hard-to-treat solid tumors using an integrated antibody-based platform.
Summary
CDR-Life is a Biotech company based in Basel, Switzerland. It has raised $76.0M in total across 1 round, most recently a $76.0M Series A round in Apr 2022. Investors include Jeito Capital, RA Capital Management and Omega Funds.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2022
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company